Infinity Pharmaceuticals(INFIQ)
$0.000.00 (0.00%)
INFIQ
Infinity Pharmaceuticals financials statements
$0.00
At close:0.00 (0.00%)
Infinity Pharmaceuticals (INFIQ) Income Statement
912 Followers
Infinity Pharmaceuticals Income Statement
Last quarter (Q2 2023), Infinity Pharmaceuticals's total revenue was $583.00K. In Q2, Infinity Pharmaceuticals's net income was $-9.96M. See Infinity Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| $ 2.59M | $ 1.86M | $ 1.72M | $ 3.05M | |
| $ 1.03M | $ 738.00K | $ 682.00K | $ -4.26M | |
| $ 45.87M | $ 45.82M | $ 39.18M | $ 41.41M | |
| Depreciation and Amortization | $ 458.00K | $ 480.00K | $ 483.00K | $ 219.00K |
| $ -43.73M | $ -44.60M | $ -37.56M | $ -44.33M | |
| $ -44.84M | $ -45.08M | $ -38.50M | $ -45.66M | |
| $ 475.00K | $ -179.00K | $ -2.00M | $ -1.45M | |
| $ -44.37M | $ -45.26M | $ -40.49M | $ -47.11M | |
| $ -44.37M | $ -45.26M | $ -40.49M | $ -47.06M | |
| Per Share Metrics | ||||
| Basic EPS | $ -0.50 | $ -0.53 | $ -0.68 | $ -0.83 |
| Diluted EPS | $ -0.50 | $ -0.53 | $ -0.68 | $ -0.83 |
| Weighted Average Shares Outstanding | 89.25M | 85.60M | 59.86M | 56.98M |
| Weighted Average Shares Outstanding (Diluted) | 89.25M | 85.60M | 59.86M | 56.98M |
Currency in USD
